{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:47:23Z","timestamp":1790884043583,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T00:00:00Z","timestamp":1078876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/sj.npp.1300417","type":"journal-article","created":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T11:15:59Z","timestamp":1078917359000},"page":"1259-1269","source":"Crossref","is-referenced-by-count":222,"title":["Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release"],"prefix":"10.1038","volume":"29","author":[{"given":"Houman","family":"Homayoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara W","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles D","family":"Tamagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,10]]},"reference":[{"key":"BF1300417_CR1","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1523\/JNEUROSCI.18-14-05545.1998","volume":"18","author":"B Adams","year":"1998","unstructured":"Adams B, Moghaddam B (1998). Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18: 5545\u20135554.","journal-title":"J Neurosci"},{"key":"BF1300417_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0006-3223(01)01195-7","volume":"15","author":"BW Adams","year":"2001","unstructured":"Adams BW, Moghaddam B (2001). Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. Biol Psychiatry 15: 750\u2013757.","journal-title":"Biol Psychiatry"},{"key":"BF1300417_CR3","first-page":"172","volume":"226","author":"D Alagille","year":"2003","unstructured":"Alagille D, Baldwin RM, Tamagnan G (2003). Synthesis and SAR of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity. American Chemical Society meeting 226: 172.","journal-title":"American Chemical Society meeting"},{"key":"BF1300417_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/35082096","volume":"411","author":"F Ango","year":"2001","unstructured":"Ango F, Prezeau L, Muller T, Tu JC, Xiao B, Worley PF et al (2001). Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 411: 962\u2013965.","journal-title":"Nature"},{"key":"BF1300417_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02245056","volume":"116","author":"AF Arnsten","year":"1994","unstructured":"Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994). Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116: 143\u2013151.","journal-title":"Psychopharmacology"},{"key":"BF1300417_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1023\/A:1012327007733","volume":"26","author":"S Attucci","year":"2001","unstructured":"Attucci S, Albani-Torregrossa S, Moroni F, Pellegrini-Giampietro DE (2001). Metabotropic glutamate receptors stimulate phospholipase D via different pathways in the adult and neonate rat hippocampus. Neurochem Res 26: 1151\u20131155.","journal-title":"Neurochem Res"},{"key":"BF1300417_CR7","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","volume":"20","author":"H Awad","year":"2000","unstructured":"Awad H, Hubert GW, Smith Y, Levey AI, Conn PJ (2000). Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci 20: 7871\u20137879.","journal-title":"J Neurosci"},{"key":"BF1300417_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1037\/0735-7044.114.1.84","volume":"114","author":"AE Baldwin","year":"2000","unstructured":"Baldwin AE, Holahan MR, Sadeghian K, Kelley AE (2000). N-methyl-D-aspartate receptor-dependent plasticity within a distributed corticostriatal network mediates appetitive instrumental learning. Behav Neurosci 114: 84\u201398.","journal-title":"Behav Neurosci"},{"key":"BF1300417_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1523\/JNEUROSCI.22-03-01063.2002","volume":"22","author":"AE Baldwin","year":"2002","unstructured":"Baldwin AE, Sadeghian K, Kelley AE (2002). Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. J Neurosci 22: 1063\u20131071.","journal-title":"J Neurosci"},{"key":"BF1300417_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1101\/lm.6.2.138","volume":"6","author":"D Balschun","year":"1999","unstructured":"Balschun D, Manahan-Vaughan D, Wagner T, Behnisch T, Reymann KG, Wetzel W (1999). A specific role for group I mGluRs in hippocampal LTP and hippocampus-dependent spatial learning. Learn Memory 6: 138\u2013152.","journal-title":"Learn Memory"},{"key":"BF1300417_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0091-3057(02)00847-X","volume":"73","author":"D Balschun","year":"2002","unstructured":"Balschun D, Wetzel W (2002). Inhibition of mGluR5 blocks hippocampal LTP in vivo and spatial learning in rats. Pharmacol Biochem Behav 73: 375\u2013380.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300417_CR12","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1523\/JNEUROSCI.22-22-09679.2002","volume":"22","author":"P Benquet","year":"2002","unstructured":"Benquet P, Gee C, Gerber U (2002). Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. J Neurosci 22: 9679\u20139686.","journal-title":"J Neurosci"},{"key":"BF1300417_CR13","first-page":"192","volume":"42","author":"D Bleakman","year":"1992","unstructured":"Bleakman D, Rusin KI, Chard PS, Glaum SR, Miller RJ (1992). Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn. Mol Pharmacol 42: 192\u2013196.","journal-title":"Mol Pharmacol"},{"key":"BF1300417_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0301-0082(98)00095-1","volume":"59","author":"F Bordi","year":"1999","unstructured":"Bordi F, Ugolini A (1999). Group I metabotropic glutamate receptors: implications for brain diseases. Prog Neurobiol 59: 55\u201379.","journal-title":"Prog Neurobiol"},{"key":"BF1300417_CR15","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/S0028-3908(00)00079-4","volume":"39","author":"V Bruno","year":"2000","unstructured":"Bruno V, Ksiazek I, Battaglia G, Lukic S, Leonhardt T, Sauer D et al (2000). Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology 39: 2223\u20132230.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR16","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1523\/JNEUROSCI.16-09-03112.1996","volume":"16","author":"WA Carlezon","year":"1996","unstructured":"Carlezon WA, Wise RA (1996). Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16: 3112\u20133122.","journal-title":"J Neurosci"},{"key":"BF1300417_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","volume":"75","author":"J Cartmell","year":"2000","unstructured":"Cartmell J, Schoepp DD (2000). Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75: 889\u2013907.","journal-title":"J Neurochem"},{"key":"BF1300417_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/S0028-3908(99)00242-7","volume":"39","author":"AG Chapman","year":"2000","unstructured":"Chapman AG, Nanan K, Williams M, Meldrum BS (2000). Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 39: 1567\u20131574.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nn0901-873","volume":"4","author":"C Chiamulera","year":"2001","unstructured":"Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S et al (2001). Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4: 873\u2013874.","journal-title":"Nat Neurosci"},{"key":"BF1300417_CR20","first-page":"1112","volume":"2","author":"E Chojnacka-Wojcik","year":"2001","unstructured":"Chojnacka-Wojcik E, Klodzinska A, Pilc A (2001). Glutamate receptor ligands as anxiolytics. Curr Opin Invest Drugs 2: 1112\u20131119.","journal-title":"Curr Opin Invest Drugs"},{"key":"BF1300417_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","volume":"37","author":"JP Conn","year":"1997","unstructured":"Conn JP, Pin J-P (1997). Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol 37: 205\u2013237.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"BF1300417_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"J Coyle","year":"1996","unstructured":"Coyle J (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3: 241\u2013253.","journal-title":"Harv Rev Psychiatry"},{"key":"BF1300417_CR23","first-page":"183","volume":"1","author":"JT Coyle","year":"2002","unstructured":"Coyle JT, Tsai G, Goff DC (2002). Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets 1: 183\u2013189.","journal-title":"Curr Drug Targets"},{"key":"BF1300417_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-8879-1","volume-title":"Spontaneous Alternation Behavior","author":"WN Dember","year":"1989","unstructured":"Dember WN, Richman CL (1989). Spontaneous Alternation Behavior. Springer-Verlag: New York. 212pp."},{"key":"BF1300417_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0028-3908(97)00001-4","volume":"36","author":"AJ Doherty","year":"1997","unstructured":"Doherty AJ, Palmer MJ, Henley JM, Collingridge GL, Jane DE (1997). (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 36: 265\u2013267.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR26","volume-title":"Psychopharmacology: The Fifth Generation of Progress","author":"M Geyer","year":"2002","unstructured":"Geyer M, Moghaddam B (2002). Animal models relevant to schizophrenia disorder. In: Davis KL, Charney C, Coyle JT and Nemeroff C (eds). Psychopharmacology: The Fifth Generation of Progress. Lippincott, Williams and Wilkins: Philadelphia."},{"key":"BF1300417_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","volume":"158","author":"DC Goff","year":"2001","unstructured":"Goff DC, Coyle JT (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158: 1367\u20131377.","journal-title":"Am J Psychiatry"},{"key":"BF1300417_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(03)12379-3","volume":"361","author":"PJ Harrison","year":"2003","unstructured":"Harrison PJ, Owen MJ (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361: 417\u2013419.","journal-title":"Lancet"},{"key":"BF1300417_CR29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0028-3908(02)00332-5","volume":"43","author":"SA Henry","year":"2002","unstructured":"Henry SA, Lehmann-Masten V, Gasparini F, Geyer MA, Markou A (2002). The mGluR5 antagonist MPEP, but not the mGluR2\/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology 43: 1199\u20131209.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02244950","volume":"111","author":"DC Hoffman","year":"1993","unstructured":"Hoffman DC, Donovan H, Cassella JV (1993). The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology (Berlin) 111: 339\u2013344.","journal-title":"Psychopharmacology (Berlin)"},{"key":"BF1300417_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF02246579","volume":"123","author":"N Hooper","year":"1996","unstructured":"Hooper N, Fraser C, Stone TW (1996). Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology 123: 250\u2013257.","journal-title":"Psychopharmacology"},{"key":"BF1300417_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301\u20131308.","journal-title":"Am J Psychiatry"},{"key":"BF1300417_CR33","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","volume":"151","author":"DC Javitt","year":"1994","unstructured":"Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J-P (1994). Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151: 1234\u20131236.","journal-title":"Am J Psychiatry"},{"key":"BF1300417_CR34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nn936","volume":"5","author":"JA Kemp","year":"2002","unstructured":"Kemp JA, McKernan RM (2002). NMDA receptor pathways as drug targets. Nat Neurosci 5: 1039\u20131042.","journal-title":"Nat Neurosci"},{"key":"BF1300417_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/jpet.103.048702","volume":"306","author":"G Kinney","year":"2003","unstructured":"Kinney G, Burno M, Campbell U, Hernandez L, Rodriguez D, Bristow L et al (2003). Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Therap 306: 116\u2013123.","journal-title":"J Pharmacol Exp Therap"},{"key":"BF1300417_CR36","first-page":"292","volume":"43","author":"G Kinney","year":"2002","unstructured":"Kinney G, Wittmann M, Bristow L, Campbell U, Conn P (2002). Behavioral consequences of mGluR5 and NMDA receptor antagonist interaction: implications for schizophrenia. Neuropharmacology 43: 292.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF00496859","volume":"48","author":"L Kokkinidis","year":"1976","unstructured":"Kokkinidis L, Anisman H (1976). Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task. Psychopharmacology 48: 261\u2013270.","journal-title":"Psychopharmacology"},{"key":"BF1300417_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00213-002-1287-8","volume":"165","author":"E Kozela","year":"2003","unstructured":"Kozela E, Pilc A, Popik P (2003). Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology 165: 245\u2013251.","journal-title":"Psychopharmacology"},{"key":"BF1300417_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","volume":"169","author":"JH Krystal","year":"2003","unstructured":"Krystal JH, D\u2019Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmaclogy 169: 215\u2013233.","journal-title":"Psychopharmaclogy"},{"key":"BF1300417_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199\u2013214.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300417_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","volume":"13","author":"AC Lahti","year":"1995","unstructured":"Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13: 9\u201319.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300417_CR42","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1523\/JNEUROSCI.17-13-05196.1997","volume":"17","author":"YM Lu","year":"1997","unstructured":"Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM et al (1997). Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 17: 5196\u20135205.","journal-title":"J Neurosci"},{"key":"BF1300417_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","volume":"81","author":"E Luby","year":"1959","unstructured":"Luby E, Cohen B, Rosenbaum G, Gottlieb J, Kelley R (1959). Study of a new schizophrenomimetic drug-sernyl. Am Med Assoc Arch Neurol Psychiatry 81: 363\u2013369.","journal-title":"Am Med Assoc Arch Neurol Psychiatry"},{"key":"BF1300417_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17: 141\u2013150.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300417_CR45","first-page":"297","volume":"43","author":"D Manahan-Vaughan","year":"2002","unstructured":"Manahan-Vaughan D, Schuetz K (2002). Differential participation of metabotropic glutamate receptor mGlu1 and mGlu5 in spatial learning and hippocampal long-term potentiation in vivo. Neuropharmacology 43: 297.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR46","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1523\/JNEUROSCI.21-16-05925.2001","volume":"21","author":"G Mannaioni","year":"2001","unstructured":"Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ (2001). Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci 21: 5925\u20135934.","journal-title":"J Neurosci"},{"key":"BF1300417_CR47","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0896-6273(03)00757-8","volume":"40","author":"B Moghaddam","year":"2003","unstructured":"Moghaddam B (2003). Bringing order to the glutamate chaos in schizophrenia. Neuron 40: 881\u2013884.","journal-title":"Neuron"},{"key":"BF1300417_CR48","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1152\/jn.1996.76.4.2794","volume":"76","author":"V Morisset","year":"1996","unstructured":"Morisset V, Nagy F (1996). Modulation of regenerative membrane properties by stimulation of metabotropic glutamate receptors in rat deep dorsal horn neurons. J Neurophysiol 76: 2794\u20132798.","journal-title":"J Neurophysiol"},{"key":"BF1300417_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.npp.1380103","volume":"11","author":"SO Ogren","year":"1994","unstructured":"Ogren SO, Goldstein M (1994). Phencyclidine and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11: 167\u2013177.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300417_CR50","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"J Olney","year":"1995","unstructured":"Olney J, Farber N (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998\u20131007.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300417_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00213-003-1432-z","volume":"167","author":"NE Paterson","year":"2003","unstructured":"Paterson NE, Semenova S, Gasparini F, Markou A (2003). The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl) 167: 257\u2013264.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300417_CR52","volume-title":"The Rat Brain in Stereotoxic Coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986). The Rat Brain in Stereotoxic Coordinates, 4th edn Academic Press: San Diego."},{"key":"BF1300417_CR53","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/sj.bjp.0700999","volume":"120","author":"A Pisani","year":"1997","unstructured":"Pisani A, Calabresi P, Centonze D, Bernardi G (1997). Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. Brit J Pharmacol 120: 1007\u20131014.","journal-title":"Brit J Pharmacol"},{"key":"BF1300417_CR54","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","volume":"106","author":"A Pisani","year":"2001","unstructured":"Pisani A, Gubellini P, Bonsi P, Conquet F, Picconi B, Centonze D et al (2001). Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience 106: 579\u2013587.","journal-title":"Neuroscience"},{"key":"BF1300417_CR55","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1073\/pnas.93.10.4693","volume":"93","author":"ME Ragozzino","year":"1996","unstructured":"Ragozzino ME, Unick KE, Gold PE (1996). Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci USA 93: 4693\u20134698.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300417_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cne.903550310","volume":"355","author":"C Romano","year":"1995","unstructured":"Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW (1995). Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455\u2013469.","journal-title":"J Comp Neurol"},{"key":"BF1300417_CR57","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1126\/science.1825731","volume":"251","author":"T Sawaguchi","year":"1991","unstructured":"Sawaguchi T, Goldman-Rakic P (1991). D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251: 947\u2013950.","journal-title":"Science"},{"key":"BF1300417_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","volume":"163","author":"R Shigemoto","year":"1993","unstructured":"Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N (1993). Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 163: 53\u201357.","journal-title":"Neurosci Lett"},{"key":"BF1300417_CR59","first-page":"1267","volume":"295","author":"WP Spooren","year":"2000","unstructured":"Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S et al (2000). Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Therap 295: 1267\u20131275.","journal-title":"J Pharmacol Exp Therap"},{"key":"BF1300417_CR60","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/0091-3057(94)90162-7","volume":"47","author":"RE Steinpreis","year":"1994","unstructured":"Steinpreis RE, Sokolowski J, Papanikolaou A, Salamone JD (1994). The effects of haloperidol and clozapine on PCP and amphetamine induced suppression of social behavior. Pharmacol Biochem Behav 47: 579\u2013585.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300417_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","volume":"12","author":"CA Tamminga","year":"1998","unstructured":"Tamminga CA (1998). Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12: 21\u201336.","journal-title":"Crit Rev Neurobiol"},{"key":"BF1300417_CR62","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0028-3908(01)00091-0","volume":"41","author":"LS Thomas","year":"2001","unstructured":"Thomas LS, Jane DE, Gasparini F, Croucher MJ (2001). Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence. Neuropharmacology 41: 523\u2013527.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR63","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0028-3908(97)00103-2","volume":"36","author":"A Ugolini","year":"1997","unstructured":"Ugolini A, Corsi M, Bordi F (1997). Potentiation of NMDA and AMPA responses by group I mGluR in spinal cord motor neurons. Neuropharmacology 36: 1047\u20131055.","journal-title":"Neuropharmacology"},{"key":"BF1300417_CR64","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1523\/JNEUROSCI.16-01-00373.1996","volume":"16","author":"A Verma","year":"1996","unstructured":"Verma A, Moghaddam B (1996). NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 16: 373\u2013379.","journal-title":"J Neurosci"},{"key":"BF1300417_CR65","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0301-0082(97)00090-7","volume":"54","author":"ME Wolf","year":"1998","unstructured":"Wolf ME (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54: 679\u2013720.","journal-title":"Prog Neurobiol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300417","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:46:03Z","timestamp":1684219563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,10]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BF1300417"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300417","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,10]]}}}